Literature DB >> 1384861

T cells and human autoimmune thyroid disease: emerging data show lack of need to invoke suppressor T cell problems.

A Martin1, T F Davies.   

Abstract

Human T cells recognize self and foreign antigens when such antigens are processed into small peptides and bound to molecules coded for by genes of the HLA region on chromosome 6. The part of the T-cell surface which is responsible for such recognition is a set of molecules coded for by a variety of genes and known as the T-cell-receptor complex. In animal models, T cells are able to transfer autoimmune thyroiditis and T cells have, therefore, long been implicated in the etiology of human autoimmune thyroid disease (AITD). Information gained from the study of intrathyroidal T cells and thyroid antigen-specific T-cell clones has shown that in patients with Graves' disease, mainly helper T-cell clones have been obtained, whereas in autoimmune (Hashimoto's) thyroiditis cytolytic T-cell clones may be predominant. Such thyroid antigen-specific T cells have now been shown to recognize one or other of the three major thyroid-specific antigens; thyroglobulin, thyroid peroxidase, or the TSH receptor and efforts are currently in progress to characterize the T-cell epitopes of these major thyroid autoantigens. Recent findings of restricted T-cell receptor V gene use amongst intrathyroidal T cells confirm the primary role of T cells in human thyroid autoimmune processes leading to AITD. However, the mechanisms whereby such autoreactive T cells escape deletion and anergy, and how they become activated, remain uncertain. There is compelling evidence that the thyroid cell itself, by expressing HLA molecules, and presenting antigen directly to the T cells, may initiate disease, perhaps after an external insult.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384861     DOI: 10.1089/thy.1992.2.247

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  8 in total

1.  Proinflammatory cytokine gene polymorphisms among Hashimoto's thyroiditis patients.

Authors:  Rong-Hsing Chen; Chwen-Tzuei Chang; Wei-Chi Chen; Chang-Hai Tsai; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

2.  p53 codon 72 proline/arginine polymorphism and autoimmune thyroid diseases.

Authors:  Rong-Hsing Chen; Chwen-Tzuei Chang; Tzu-Yuan Wang; Wen-Liang Huang; Chang-Hai Tsai; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

3.  The association between serum 25OHD levels and hypothyroid Hashimoto's thyroiditis.

Authors:  Nasrin Mansournia; Mohammad Ali Mansournia; Sandra Saeedi; Jafar Dehghan
Journal:  J Endocrinol Invest       Date:  2014-03-18       Impact factor: 4.256

4.  Human organ-specific autoimmune disease. Molecular cloning and expression of an autoantibody gene repertoire for a major autoantigen reveals an antigenic immunodominant region and restricted immunoglobulin gene usage in the target organ.

Authors:  G D Chazenbalk; S Portolano; D Russo; J S Hutchison; B Rapoport; S McLachlan
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

5.  Lack of association between interleukin-4 gene polymorphisms and autoimmune thyroid diseases amongst Taiwanese Chinese.

Authors:  Rong-Hsing Chen; Chwen-Tzuei Chang; Tzu-Yuan Wang; Ching-Chu Chen; Chang-Hai Tsai; Fuu-Jen Tsai
Journal:  Endocrine       Date:  2007-12-05       Impact factor: 3.633

6.  Immunogenetics of Hashimoto's thyroiditis.

Authors:  Dimitry A Chistiakov
Journal:  J Autoimmune Dis       Date:  2005-03-11

7.  Single-Cell Chromatin Accessibility Data Combined with GWAS Improves Detection of Relevant Cell Types in 59 Complex Phenotypes.

Authors:  Akash Chandra Das; Aidin Foroutan; Brian Qian; Nader Hosseini Naghavi; Kayvan Shabani; Parisa Shooshtari
Journal:  Int J Mol Sci       Date:  2022-09-28       Impact factor: 6.208

Review 8.  Coronavirus Disease 2019 and the Thyroid - Progress and Perspectives.

Authors:  Hidefumi Inaba; Toru Aizawa
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-24       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.